Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6BHV

Human PARP-1 bound to NAD+ analog benzamide adenine dinucleotide (BAD)

Summary for 6BHV
Entry DOI10.2210/pdb6bhv/pdb
DescriptorPoly [ADP-ribose] polymerase 1, [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylphenyl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) (3 entities in total)
Functional Keywordsparp-1, artd1, poly(adp-ribose) polymerase, non-hydrolyzable nad+ analog, parp, adp-ribose, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains4
Total formula weight122662.85
Authors
Pascal, J.M.,Langelier, M.F. (deposition date: 2017-10-31, release date: 2018-02-28, Last modification date: 2023-10-04)
Primary citationLangelier, M.F.,Zandarashvili, L.,Aguiar, P.M.,Black, B.E.,Pascal, J.M.
NAD+analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains.
Nat Commun, 9:844-844, 2018
Cited by
PubMed Abstract: PARP-1 cleaves NAD and transfers the resulting ADP-ribose moiety onto target proteins and onto subsequent polymers of ADP-ribose. An allosteric network connects PARP-1 multi-domain detection of DNA damage to catalytic domain structural changes that relieve catalytic autoinhibition; however, the mechanism of autoinhibition is undefined. Here, we show using the non-hydrolyzable NAD analog benzamide adenine dinucleotide (BAD) that PARP-1 autoinhibition results from a selective block on NAD binding. Following DNA damage detection, BAD binding to the catalytic domain leads to changes in PARP-1 dynamics at distant DNA-binding surfaces, resulting in increased affinity for DNA damage, and providing direct evidence of reverse allostery. Our findings reveal a two-step mechanism to activate and to then stabilize PARP-1 on a DNA break, indicate that PARP-1 allostery influences persistence on DNA damage, and have important implications for PARP inhibitors that engage the NAD binding site.
PubMed: 29487285
DOI: 10.1038/s41467-018-03234-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon